CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 76 filers reported holding CUE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,736,564 | -37.0% | 755,028 | 0.0% | 0.43% | -23.4% |
| Q2 2023 | $2,755,852 | +2.2% | 755,028 | 0.0% | 0.56% | -2.8% |
| Q1 2023 | $2,695,450 | +9.8% | 755,028 | -12.3% | 0.58% | +7.9% |
| Q4 2022 | $2,454,642 | +98.3% | 861,278 | +55.2% | 0.53% | +106.6% |
| Q3 2022 | $1,238,000 | -10.4% | 555,000 | 0.0% | 0.26% | -9.5% |
| Q2 2022 | $1,382,000 | -48.7% | 555,000 | +0.5% | 0.28% | -40.4% |
| Q1 2022 | $2,694,000 | +19.1% | 552,000 | +176.0% | 0.48% | +35.4% |
| Q4 2021 | $2,262,000 | -11.3% | 200,000 | +14.3% | 0.35% | -14.7% |
| Q3 2021 | $2,550,000 | +25.1% | 175,000 | 0.0% | 0.41% | +34.4% |
| Q2 2021 | $2,039,000 | +11.4% | 175,000 | +16.7% | 0.31% | +97.4% |
| Q1 2021 | $1,830,000 | +95.1% | 150,000 | +100.0% | 0.16% | -14.8% |
| Q4 2020 | $938,000 | -58.5% | 75,000 | -50.0% | 0.18% | -54.7% |
| Q3 2020 | $2,258,000 | -44.2% | 150,000 | -9.1% | 0.40% | -43.5% |
| Q2 2020 | $4,044,000 | +72.7% | 165,000 | 0.0% | 0.72% | +16.8% |
| Q1 2020 | $2,341,000 | -10.6% | 165,000 | 0.0% | 0.61% | +47.5% |
| Q4 2019 | $2,619,000 | – | 165,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |